Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietCardiovascularObesityType 2 DiabetesIssue 729

The Potential of Low-Carbohydrate Diets to Reduce CVD Risk

Consuming low-carbohydrate diets can reduce inflammation in patients with type 2 diabetes which may decrease the risk of patients developing cardiovascular disease.... 

Advertisement

According to a Swedish study, eating a low-carbohydrate diet can reduce inflammation in patients with type 2 diabetes. People with type 2 diabetes have a higher level of inflammation than those without diabetes, and this may play a part in the increased risk of cardiovascular disease associated with diabetes. The Linkoping University study included 61 participants with type 2 diabetes. The participants were randomly divided up and given either a low-carbohydrate or low-fat diet. The study method was a retrospective follow-up. The low-carbohydrate diet and the low-fat diet were compared over the course of 2 years. Additionally, the researchers studied how the diets impacted inflammation by checking the inflammation levels in the blood of each patient.

The results showed that both the low-carbohydrate and low-fat diets helped participants lose weight, roughly around nine pounds, but when it came to which diet produced reduced inflammatory markers in the blood, the low-carbohydrate diet succeeded. Additionally, glucose-levels dropped more in the low-carbohydrate diet groups. The researchers recommended with respect to the cardiovascular risk involved, aiming carbohydrate energy intake to 20% as a treatment alternative for at-risk patients.

Practice Pearls:
  • Low-carbohydrate diets help aid in weight loss as well as reduce inflammatory markers in the blood, and drop glucose-levels
  • Reducing inflammation in patients with type 2 diabetes may have potential to decrease the risk of patients developing cardiovascular diseases in the future
  • With respect to the cardiovascular risk involved, aim carbohydrate energy intake to 20%, which can be established as a treatment alternative

Diabetologia. 2012 Aug;55(8):2118-27. doi: 10.1007/s00125-012-2567-4. Epub 2012 May 6

  

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  DietCardiovascularObesityType 2 DiabetesIssue 729

Past five issues: Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 | Issue 763 |

2014 Most Popular Articles:

ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Why a Low-Carb Diet Should Be the First Approach in Diabetes Treatment
Posted December 18, 2014
Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Type 2 Diabetes Risk Lower for Blood Type O
Posted December 26, 2014
Early Insulin Therapy Makes an Impact
Posted December 26, 2014
Increased Mortality with Combining Sulfonylurea and Insulin
Posted December 26, 2014
Another SGLT2 Shows Positive Results
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you comfortable recommending one of the 4 new FDA-approved weight loss drugs?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control